- Home
- ROIV vs AIZ Comparison
ROIV vs AIZ Comparison
Compare ROIV & AIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- AIZ
- Stock Information
- Founded
- ROIV 2014
- AIZ 1892
- Country
- ROIV United Kingdom
- AIZ United States
- Employees
- ROIV 750
- AIZ N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- AIZ Property-Casualty Insurers
- Sector
- ROIV Health Care
- AIZ Finance
- Exchange
- ROIV Nasdaq
- AIZ Nasdaq
- Market Cap
- ROIV 14.1B
- AIZ 11.4B
- IPO Year
- ROIV N/A
- AIZ N/A
- Fundamental
- Price
- ROIV $20.73
- AIZ $228.49
- Analyst Decision
- ROIV Strong Buy
- AIZ Buy
- Analyst Count
- ROIV 8
- AIZ 6
- Target Price
- ROIV $21.19
- AIZ $249.17
- AVG Volume (30 Days)
- ROIV 8.4M
- AIZ 305.1K
- Earning Date
- ROIV 11-10-2025
- AIZ 11-04-2025
- Dividend Yield
- ROIV N/A
- AIZ 1.55%
- EPS Growth
- ROIV N/A
- AIZ 17.21
- EPS
- ROIV N/A
- AIZ 16.41
- Revenue
- ROIV $20,329,000.00
- AIZ $12,568,700,000.00
- Revenue This Year
- ROIV N/A
- AIZ $7.85
- Revenue Next Year
- ROIV $320.50
- AIZ $4.82
- P/E Ratio
- ROIV N/A
- AIZ $13.80
- Revenue Growth
- ROIV N/A
- AIZ 6.92
- 52 Week Low
- ROIV $8.73
- AIZ $174.97
- 52 Week High
- ROIV $21.35
- AIZ $232.02
- Technical
- Relative Strength Index (RSI)
- ROIV 67.12
- AIZ 64.04
- Support Level
- ROIV $19.99
- AIZ $224.69
- Resistance Level
- ROIV $20.99
- AIZ $230.00
- Average True Range (ATR)
- ROIV 0.74
- AIZ 4.40
- MACD
- ROIV -0.19
- AIZ 0.28
- Stochastic Oscillator
- ROIV 59.94
- AIZ 78.31
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About AIZ Assurant Inc.
Assurant Inc is a protection company that partners with the brands to safeguard and service connected devices, homes and automobiles. It operate in North America, Latin America, Europe and Asia Pacific through two operating segments: Global Lifestyle and Global Housing. Global Lifestyle: includes mobile device solutions (including extended service contracts, insurance policies and related services), extended service contracts and related services for consumer electronics and appliances, and financial services and other insurance products. Global Housing: includes lender-placed homeowners, manufactured housing and flood insurance, as well as voluntary manufactured housing, condominium and homeowners insurance. Key revenue is generated from Global Lifestyle segment.